NOV Inc. Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? NOV Inc. Common Stock trades at $18.97 (market cap $6.77B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 6× NOV Inc. Common Stock's market cap, and NOV Inc. Common Stock pays a 1.9% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NOV Inc. Common Stock for 1 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| NOV | RVMD | |
|---|---|---|
Market Cap | $6.77B | $40.32B |
Volume | 3,592,724 | 4,855,734 |
Sector | Energy | Health |
52-Week High | $21.71 | $221.15 |
52-Week Low | $12.31 | $47.50 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $7.93B | $37.02B |
Dividend Yield | 1.9% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →